Biologics and CAR-Ts for Autoimmune with William Strohl, Pres.t & Owner, BiStro Biotech Consulting
Interview with Simon Letarte of Gilead: Novel Approach to Integration of Characterization Data
Exploring in vivo CAR-T with Adrian Bot, CSO and EVP, R&D, Capstan Therapeutics
Radiopharmaceutical Therapies Challenges & Changes | Expert Insights from Shaemus Gleason
View By:
May 12-13
Display of Biologics
Antibodies for Cancer Therapy
Advances in Immunotherapy
Difficult-to-Express Proteins
ML and Digital Integration in Biotherapeutic Analytics
Biologics for Immunology Indications
May 13-14
Engineering Antibodies
Advancing Multispecific Antibodies
Emerging Targets for Oncology and Beyond
Engineering Cell Therapies
Optimizing Protein Expression
Biophysical Methods
Predicting Immunogenicity with AI/ML Tools
Radiopharmaceutical Therapies
May 15-16
Machine Learning for Protein Engineering
Driving Clinical Success in Antibody-Drug Conjugates
Engineering Bispecific and Multifunctional Antibodies
Next-Generation Immunotherapies
Maximizing Protein Production Workflows
Characterization for Novel Biotherapeutics